0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Psychiatry | 
Research Letter |  ONLINE FIRST
Mehmet Burcu, MS; Julie M. Zito, PhD; Leanne Metcalfe, PhD; et al.
JAMA Psychiatry. Published online June 22, 2016. doi:10.1001/jamapsychiatry.2016.1182

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(23):2514. doi:10.1001/jama.2016.7382.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(23):2514. doi:10.1001/jama.2016.7384.

JAMA Psychiatry | 
Editorial |  ONLINE FIRST
Gerard Sanacora, MD, PhD
JAMA Psychiatry. Published online June 15, 2016. doi:10.1001/jamapsychiatry.2016.0780

JAMA Psychiatry | 
Original Investigation |  ONLINE FIRST
Jorge A. Quiroz, MD, MBA; Paul Tamburri, PharmD; Dennis Deptula, PhD; et al.
JAMA Psychiatry. Published online June 15, 2016. doi:10.1001/jamapsychiatry.2016.0838
Includes: Supplemental Content

JAMA | 
Original Investigation | 
Wayne A. Ray, PhD; Cecilia P. Chung, MD, MPH; Katherine T. Murray, MD; et al.
JAMA. 2016;315(22):2415-2423. doi:10.1001/jama.2016.7789.
Includes: Supplemental Content

JAMA Psychiatry | 
Original Investigation |  ONLINE FIRST
M. Katherine Shear, MD; Charles F. Reynolds III, MD; Naomi M. Simon, MD, MSc; et al.
JAMA Psychiatry. Published online June 08, 2016. doi:10.1001/jamapsychiatry.2016.0892
Includes: Supplemental Content

JAMA Psychiatry | 
Original Investigation | 
Willem Kuyken, PhD; Fiona C. Warren, PhD; Rod S. Taylor, PhD; et al.
JAMA Psychiatry. 2016;73(6):565-574. doi:10.1001/jamapsychiatry.2016.0076.
Includes: Supplemental Content

JAMA Internal Medicine | 
Original Investigation | 
Michael E. Johansen, MD, MS; Caroline Richardson, MD
JAMA Intern Med. 2016;176(6):769-775. doi:10.1001/jamainternmed.2016.1704.
Includes: Supplemental Content

JAMA Psychiatry | 
Original Investigation | 
Joseph F. Hayes, MSc, MBChB; Alexandra Pitman, PhD; Louise Marston, PhD; et al.
JAMA Psychiatry. 2016;73(6):630-637. doi:10.1001/jamapsychiatry.2016.0432.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Research Letter  | 
Trends in Stimulant Medication Use in Commercially Insured Youths and Adults, 2010-2014
Mehmet Burcu, MS; Julie M. Zito, PhD; Leanne Metcalfe, PhD; et al.
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Antipsychotic Drug May Cause Impulse-Control Problems
Rebecca Voelker, MSJ
JAMA Psychiatry
Editorial  | 
What Are We Learning From Early-Phase Clinical Trials With Glutamate Targeting Medications for the Treatment of Major Depressive Disorder
Gerard Sanacora, MD, PhD